WEISMAN HOWARD J. (Chief Executive Officer) reported 1 transaction at KUVATRIS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/28/2023ACC: 0001104659-23-052957
DirectorOfficer· Chief Executive Officer
Since Aug 2022
-9.95K
Net shares
Net seller
$16.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.95K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.95K
Price / share
$1.61
Trade value
$16.02K
% of position
1.4%
4/26/2023
721.63K→711.68K
Total
Net shares
−9.95K
Net value
-$16.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/26/2023 | F · Tax Withholding | −9.95K | $1.61 | $16.02K | 1.4% | 721.63K | 711.68K |
| Total | −9.95K | -$16.02K | ||||||
Derivative Transactions0
No derivative transactions reported